Evidence map›Paper›PMID 39020213›Full record

ArticleNature biotechnology2024

A community effort to track commercial single-cell and spatial 'omic technologies and business trends.

Joachim De Jonghe, James W Opzoomer, Amaia Vilas-Zornoza, Peter Crane, Benedikt S Nilges, Marco Vicari, Hower Lee, David Lara-Astiaso, Torsten Gross, Jörg Morf and 15 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Joachim De Jonghe *Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0584-8265
James W Opzoomer *Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK.
Amaia Vilas-Zornoza *Relation Therapeutics, London, UK.
Peter Crane *Caeruleus Genomics, Oxford, UK.
Benedikt S NilgesOMAPiX GmbH, Langenfeld, Germany.
Marco VicariScience for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Solna, Sweden.ORCID http://orcid.org/0000-0002-3042-6278
Hower Leespatialist AB, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8781-3623
David Lara-AstiasoWellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.
Torsten GrossRelation Therapeutics, London, UK.
Jörg MorfSkyhawk Therapeutics, Basel, Switzerland.ORCID http://orcid.org/0000-0002-0485-3380
Kim SchneiderRoche, Basel, Switzerland.
Juliana CudiniRelation Therapeutics, London, UK.
Lorenzo Ramos-MucciRelation Therapeutics, London, UK.
Dylan MooijmanSingle Cell Discoveries, Utrecht, the Netherlands.
Katarína TiklováScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden.
Sergio Marco Salasspatialist AB, Stockholm, Sweden.
Christoffer Mattsson Langsethspatialist AB, Stockholm, Sweden.
Nachiket D KashikarOMAPiX GmbH, Langenfeld, Germany.ORCID http://orcid.org/0000-0002-4466-7486
Charles E S RobertsRelation Therapeutics, London, UK.
scTrends Consortium
Joakim LundebergScience for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Solna, Sweden.ORCID http://orcid.org/0000-0003-4313-1601
Mats NilssonScience for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden.ORCID http://orcid.org/0000-0001-9985-0387
Alex K ShalekRelation Therapeutics, London, UK.ORCID http://orcid.org/0000-0001-5670-8778
Adam P CribbsCaeruleus Genomics, Oxford, UK.ORCID http://orcid.org/0000-0001-5288-3077
Jake P Taylor-KingRelation Therapeutics, London, UK. jake@relationrx.com.ORCID http://orcid.org/0000-0002-1025-0041

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Single-Cell AnalysisCommerceGenomicsHumans

Identifiers

PMID39020213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.